864070-44-0

We have more than 10 years of experience in custom synthesis of compounds. If you are looking for a supplier or manufacturer of Empagliflozin (CAS No.: 864070-44-0) please contact us. We can provide customers with custom synthesis from grams to kilograms and the production of tons of compounds. Now, we also hope to meet your needs for Empagliflozin (CAS No.: 864070-44-0) and other compounds. We can provide high-quality compounds and good service for you.

Send Inquiry

Product Description

Name	Empagliflozin
Synonyms	X5927;(2S,3R,4R,5S,6R)-2-(4-chloro-3-(4-((S)-tetrahydrofuran-3-yloxy)benzyl)phenyl)-6-(hydroxymethyl)tetrahydro-2H-pyran-3,4,5-triol;Empagliflozin;CS-0940
Molecular Formula	C₂₃H₂₇ClO₇
Molecular Weight	450.90900
CAS Number	864070-44-0
purity	≥99%
Storage conditions	Sealed in dry,2-8°C
Availability	In stock

Application: Empagliflozin (CAS No.: 864070-44-0) is a new generation SGLT2 inhibitor (type 2 sodium-glucose transporter inhibitor) approved by the U.S. Food and Drug Administration (FDA) in August 2014 for the treatment of adults with type 2 diabetes mellitus in combination with diet and exercise. Englistin reduces the ability of the kidneys to recycle glucose back into the bloodstream and allows sugar to be excreted through the urine, significantly reducing patients' blood glucose levels, risk of kidney and cardiovascular disease, overweight and blood pressure. Different from other oral drugs currently used in the treatment of type 2 diabetes, englisin is the first SGLT2 class hypoglycemic agent to complete the cardiovascular prognosis study, and it is the only oral hypoglycemic agent to be proved to have the efficacy of controlling glucose, protecting heart, protecting kidney and reducing body weight.

Hot Tags: